Pediatric/adolescent gyn Flashcards
what are classification for vulvovaignitis in peds/adolescent?
- non-specific
- infectious
how do you diagnose non-specific vulvovaginitis?
- diagnosis of exclusion
- history and physical
treatment non-specific vulvovaginitis?
perineal hygeine
- wiping front to back after BM
- sitz baths
- cotton underwear/loose fitting clothing
what are infectious causes of vulvovaginitis in PAG?
both respiratory and fecal source
- group A strep
- strep pyogenes
- H. influenza
- e. Coli
- Shigella
- yersinia
- pinworms (enterobiasis) -> scotch tape test-> tx with mebendazole
always consider G/C/T
in girls, GC needs to be cx not NAAT
management of labial adhesions?
- if asymptomatic -> observe with emphasis on vulvar hygeine
- if symptomatic:
topical estrogen twice daily x 6 weeks (rub cream into line of scar with qtip and gentle lateral traction of labia)
if severely symptomatic:
- can consider manual release with topical anesthetic
- surgical intervention
post-release care: bland emollient on labia to maintain separation
what is differential for vulvar conditions of PAG?
non-infectious
- lichen sclerosus
- lichen simplex chronicus, atopic or contact dermatitis
- labial adhesions
infectious
- molluscum contagiosum
- hsv
- condyloma accuminata
how do you diagnose/treat molluscum contagiosum?
- clinical impression: 1-5 mm plaque like, dome shaped, smooth, “umbilicated lesion”
- typically due to overcrowded/hygeine
- usually observation
- if tx needed, can try cryosurgery, silver nitrate, curettage, imiquimod approved for age > 12
how to manage condyloma accuminata in PAG?
- can be perinatal transmission of HPV, but have to consider sexual abuse
- observation if possible
- if tx desired: destructive or excisional options; topical immiquimod age > 12
- high recurrence rate
HSV in PAG
beyond neonatal period, sexual abuse has to be considered
- acyclovir approved in children over 2 years
lichen sclerosus diagnosis and management in PAG?
- diagnosis by exam. treat with high dose topic corticosteroid. if persistent or lesion is atypical, only then bx. if failed corticosteroid, can try topical calcineurin inhibitor (tacrolimus, pimecrolimus)
- high risk of recurrence after stopping treatment up to 80%
- unknown cancer risk
- recommended surveillance q6-12 mo
- evaluation for other autoimmune conditions